-
Mashup Score: 3New Horizons in Amyloidosis - 1 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3New Horizons in Amyloidosis - 1 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 11New Horizons in Amyloidosis - 2 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0New Horizons in Amyloidosis - 2 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1New Horizons in Amyloidosis - 2 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet-
Don't miss our upcoming live event discussing the importance of #CardiacMRI in evaluating cardiac amyloidosis. Register today 👉 https://t.co/GszrCvgbxT #Cardiology #CardiacHealth #MedEd #WhyCMR This breakout is sponsored by Circle Cardiovascular Imaging @sven_plein @KanaeMukai https://t.co/d60Zqu2wPo
-
-
Mashup Score: 6New Horizons in Amyloidosis - 3 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2New Horizons in Amyloidosis - 3 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9New Horizons in Amyloidosis - 3 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet-
⚡️NHA IME Symposium | ATTR-CM: Where Are We Now and Where to Next? Register FREE 🔗 https://t.co/pBcRi9TF8t Join Prof @FinnGustafsson, Prof @dr_m_fontana and Dr @MasriAhmadMD on 28 February for an interactive discussion on: ⚙️Current methods used to measure success in treating… https://t.co/t7mycUltDZ https://t.co/0uPjC9GvJG
-
-
Mashup Score: 9New Horizons in Amyloidosis - 3 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Partners & KOLsTweet-
⚡️NHA IME Symposium | ATTR-CM: Where Are We Now and Where to Next? Register FREE 🔗 https://t.co/pBcRi9TF8t Join Prof @FinnGustafsson, Prof @dr_m_fontana and Dr @MasriAhmadMD on 28 February for an interactive discussion on: ⚙️Current methods used to measure success in treating… https://t.co/t7mycUltDZ https://t.co/0uPjC9GvJG
-
-
Mashup Score: 11New Horizons in Amyloidosis - 3 month(s) ago
Join me at #NHA24 – A 1-day event on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field
Source: www.newhorizonsinamyloidosis.comCategories: General Medicine News, Onc News and JournalsTweet
Discover the latest developments in diagnosing cardiac amyloidosis, current & emerging treatments, multidisciplinary care strategies, and improving patient outcomes from #NewHorizonsAmyloidosis2024. Led by Dr Falk & Prof Hawkins, it's a must-watch 👉 https://t.co/QqMpFFYtzY https://t.co/z2IQ87RIy9